Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Biogen Idec reports death of patient on its MS pill
Ethnicity and prevalence of multiple sclerosis in east London.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages.
Genpharm and Genzyme Aubagio ® agreement for the MENA region
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Regenerative cellular therapies for neurologic diseases.
Current and future immunotherapy targets in autoimmune neurology.
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Multiple sclerosis: A lifestyle disease?
Pathogenic implications of iron accumulation in multiple sclerosis.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Product Portfolio, Meda
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Erratum to: Antibody-mediated neutralization of myelin-associated EphrinB3 accelerates CNS remyelination.
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.

Pages